The role of nitrosamines in food by Ramli, Johari
UPM Research Report 1997-2000, Section 2-Extended Abstracts
JohariRamli
The Role of Nitrosamines in Food*
Facultyof ScienceandEnvironmentalStudies
UniversitiPutraMalaysia
43400UPM,Serdang,Selangor
Malaysia
E-mail ofCorrespondingAuthor:johari@fsas.upm.edu.my
Key words: nitrosamines, phase II enzymes, liver, histology, marker enzymes.
Introduction
In the twentieth century, cancer has
become one of the most important
killer diseases in the world and has
being studied as an important biomedi-
cal research area over the past few
decades. Approximately a hundred
types of human cancer have been rec-
ognised and epidemiological studies
have showed about 35% of cancer are
related to the diet. It is well docu-
mented that different types of carcino-
genic stimuli, including chemicals,
viruses and radiation, induce cancer
development in organs and tissues. In
the modem industrialized world, cancer
has become the most feared of all dis-
eases. It is a progressively fatal disease
for which no treatment has yet been
discovered. Studies have been carried
out histologically and histochemically
but only a few studies have attributed
correlation between biochemical assay
and histological effects. Thus the car-
cinogenic process in mice liver and
kidney with intra-peritoneal injection
with N-Nitrosodimethylamine
(NOMA) at sub-acute, acute and
chronic doses were analysed by moni-
toring the marker enzymes of liver
cancer namely gamma glutamyl
transpeptidase, Phase IIenzymes glu-
tathione S-transferase and uridyl di-
phosphoglucuronyl transferase. Their
activities are significant in evaluation
of disease progression and promotion
during treatment and developments of
cancer that makes them as an important
1001 for cancer research especially for
liver cancer. By using N-Nitrosamines
as a cancer agent, understanding of
carcinogenesis as a multistage process
and evaluation in developments can
establish an ideal way of detecting this
disease at an earlier stage which is one
of the objectives beside analysis of the
damages to liver cells caused by this
potent chemical. Hepatocarcinoma are
detected in most cases only after it
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enters the chronic stage. This is due to
unavailability of any symptoms at ear-
lier stages. Therefore it is important to
obtain early markers during hepatocar-
cinogenesis in order to save and/or
prolong life or for earlier treatments.
Thus nitrosamine such as NOMA serve
the purpose due to its metabolic activ-
ity being mainly centralized in liver as
a major metabolic organ and participa-
tion of these detoxifying enzymes are
shown to be sensitive to changes dur-
ing this series of treatment.
Materials and Methods
Male adult mice Mus musculus with an
average weight of 26-32gm were pur-
chased from the Institute of Medical
Research (IMR). NOMA were pur-
chased from Sigma Chemical.
Co.USA. Animals were maintained
with free access to food and water ad
libitum, and in a well-ventilated room.
For intraperitonial treatment, NOMA
solutions were prepared by dissolving
in 0.9% saline and administered to
mice on the ratio ofO.5, 2.5 and
0.05mg/kg of body weight at different
times of exposure. The i.p injection
was given based on L050 value for
mice ie: 7-14 mg/kg of body weight to
produce renal tumour and hepatocellu-
lar carcinoma (Frei, 1970). For long-
term oral administration on mice L050
23-40mg/kg of body weight of NOMA
was used as standard in preparing sub-
necrogenic doses for mice. Cytosolic
and microsomal fractions were pre-
pared using the method of Speir and
Wattenburg (1975). Animals were
sacrificed by neck dislocation and the
organs were homogenised in volume of
1:3 buffer 1.15% KCL and then centri-
fuged further at 9000 x g for 60 min-
utes at 4C. The homogenate were cen-
trifuged again at 105,000 x g after
saving some homogenate for ALP
analysis. The supematant obtained
contain the cytosol fraction and the
pellet contains the microsomes. The
cytosolic fraction was used for assay
of GSH-Px, GST and GSH-R and mi-
crosome fraction was used for assay of
UDPGT and GGT enzymes. GGT was
assayed according to the method of
Jacobs et al. (1971). L-glutmyl-
carboxyl-nilroanilide was used as sub-
strate and glycylglycine was used as
gamma glutamy acceptor. The absorb-
ance of the final mixture was measured
at 405nm. The assay of GST activity in
liver and kidney cytosol was done ac-
cording to the method of Habig et.al,
1974. The reaction mixture consists of
200ul of sample, ImM of CDNB,
%mM GSH and 0.1M phosphate buffer
in a total volume of 3m!. The absorb-
ance of the sample was read against the
blank at 340nm and a unit of enzyme
activity is defined as the amount of
enzyme activity that catalyses the for-
mation of Iumol of the substrate with
GSH per minute at 29°C.
Results and Discussion
Acute doses given at a single dose of
O.5mg/kg of body weight had signifi-
cantly increased the GST activity in
liver but not in kidney. During sub-
chronic and chronic dose treatment of
0.25 and 0.05mg/kg of body weight
had significantly increased the liver
and kidney GST respectively. Glutathi-
one reductase and Glutathione peroxi-
dase are two enzymes that are involved
in glutathione metabolism and in this
study their activity shows a significant
increase in liver during acute chronic
and sub-chronic exposure and not
highly expressed in kidney during i.p
injection of NOMA in mice. During
acute exposure GGT shows marginal
decrease in specific activity both in
liver and kidney compared to control.
Another metabolizing enzyme UDPGT
was significantly increased at three
different levels of exposures in both
metabolic organs suggesting their in-
volvement in NOMA metabolization
during i.p injection to male mice.
Applied Sciences and Technologies
When histological lesion studies were
done, liver tissues show a higher de-
gree of cellular degeneration in all
treated groups with enlarged Kupffer
cells and the presence of neutrophiles.
The metabolic activation of N-
Nitrosocompounds are known to take
place predominantly in the liver and
kidney and especially NOMA are
known to exert cytotoxic, mutagenic
and carcinogenic effects in various
tissues in animal species. GSH is
known as a very important substrate in
the liver for the detoxification proc-
esses of xenobiotic substances. It is
well recognised that GSH and GSH
related enzymes play important roles in
the protection of mammalian cells
against the harmful effects of chemical
carcinogenesis and other alkylating
agents (Lotlikar et,al., 1980; Ketterer et
al., 1988). When cytosolic GST activi-
ties were measured in kidney and liver,
its activities are significantly increased
in treated groups of chronic, sub-
chronic and acute groups. The placen-
tal form of GST is absent from normal
liver but found in kidney and in hepatic
preneoplastic lesions (Ogita and Mark-
ert, 1990). The GST activity are re-
ported to be increased during reversion
of cells to the fetal-like state and there-
fore this result can be an indication of
treated cell being reverted to those in
embryonic state which serve the pur-
pose as a useful marker during hepato-
carcinogenesis. The active metabolites
possibly exert their toxic effects in the
liver or might be transported from liver
via the blood elsewhere e.g kidney.
GSH-R, is an important enzyme in
protection of mammalian cells against
toxicants and in this work it has been
shown that elevated level of activities
are only found in liver but not in kid-
ney. This has been suggested to be an
adaptive response in order to compen-
sate for the depleted level of GSH by
reduction of oxidized to GSH. Since
liver is the major organ in GSH cycle,
thus the presence of this enzymes re-
semble the importance of liver as a
metabolic organ. The increase of GSH-
Px activity, another GSH cycle enzyme
are due to increased oxidized glutathi-
one formation. Kitahara et.al, in 1984
had shown that certain molecular forms
ofGST such as GST-A, GST-AA, and
GST-B possess GSH-Px activity. It has
been reported that GST-B acts like
GSH-Px in hyperplastic nodules partly
to compensate for the decreased sele-
nium dependant GSH-Px activity dur-
ing hepatocarcinogenesis. Another
important enzyme which catalyses the
breakdown of GSH in tissue is GGT,
which possess high activity in fetal and
in hepatoma but very low activity in
the adult rat liver (Taniguchi et.al,
1975). Since its usefulness as an early
marker of early neoplasia and severity
of hepatocarcinogenesis this enzyme
are expected to increase in treated liver
sample. The result obtained shows that
the percentage of enzyme activities in
both liver and kidney decreased at
acute stages and gradually increased at
sub-chronic period and again increased
at chronic stages. The first increase of
the enzyme protein is a reflection of
appearance of pre-neoplastic lesion and
the second increase of the protein is the
reflection of hepatoma cells (Sato et.al,
1983). Previous studies reported the
changes of enzyme contents are con-
sistent with those determined by en-
zyme inmmunoassay. Another micro-
somal enzyme UOPGT in treated liver
increases significantly compared to
control and also compared to kidney.
The results in this study agrees with
Bock et.al, 1982, where he has shown
an increase in liver UOPGT in pre-
neoplastic liver after treatment with 2-
Acetylaminofluorene. This is perhaps
due to glucuronidation of the toxic
compound during the tumour promo-
tion phase II by the carcinogen. The
bio-activation of NOMA are found to
be greater in liver and in histological
sectioning it has been shown that a
single acute doses of NOMA could
cause necrosis in liver but not in kid-
ney.
Conclusions
Majority of tumour marker enzyme
activities (GST, GSH-R, GSH-Px,
GGT and UOPGT) increased in liver
and kidney induced by NOMA. In the
liver, acute, sub-chronic and chronic
exposure to NOMA showed increase
enzyme activities in comparisons with
control group. In the kidney however
the effect of NOMA exposure was
rather inconsistent. For instance all
enzyme activities-increase in acute
exposure. In the ~'lb-chronic and
hroni "c me exposure some enzymes activ-
ity increased (for sub-chronic: GST,
GGT and UOPGT) and some enzyme
activities did not significantly change
(for e.g: subchronic and chronic: GSH-
R). Hence kidney and liver appear to
be the main target organs of the car-
cinogenic action of NOMA in mice.
Prolonged exposures of mice to
NOMA produce a high incidence of
hepatocellular adenoma tumour. This
study demonstrated that there is very
clear correlation between enzyme ac-
tivity and cell damage, therefore it is
possible that these enzymes activities
can be used as a tumour marker in
future research.
Benefits from the study
By measuring he biochemical parame-
ters GGT, GST, UOPGT and GSH-r
together with GSh-Pr, provides an
opportunity to identify any disease
prone in li ver at earlier stage. This will
enhance the capability of metabolic
organs to minimize or eliminate the
toxicity of carcinogen when absorbed
in body. The disruption of these bio-
chemical markers during clinical as-
sessment is significant in monitoring
the progress of any liver related treat-
ment. Beside, these biochemical pa-
rameters are useful when studies are
conducted on drugs and medicinal
products in order to look at the binding
capability or induction property in
metabolic organs by measuring these
enzymes. Any accidental exposure also
can be prevented by analyzing the
compounds toxicity by looking at labo-
ratory animals on these liver markers.
Induction and activation of these en-
zymes can provide good susceptibility
against any liver disorders thus main-
taining healthy cycle of blood, which
yield better health condi tion.
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